Skip to content
OpenCapital
Get started

DaVita DVA U.S.Dialysis And Related Lab Services — Revenue

Similar metrics at other companies

Baxter International logo
BAXRenal Care — Net Sales
$936M+0.5%
Baxter International logo
BAXChronic Renal — Net Sales
$917M+11,563%
Quest Diagnostics logo
DGXRoutine clinical testing services — Net revenues
$901M-12.0%
Baxter International logo
BAXRenal — Net Revenue
$1.01B+3.4%
Quest Diagnostics logo
DGXRoutine clinical testing and other services — Net revenues
$1.12B-7.5%
Baxter International logo
BAXKidney Care — Net Sales
$1.12B+0.2%

Other financials

Income statement

See full
Revenue$3.4B+6.0%
Operating income$481.9M+9.8%
Net income$197.5M+21.2%
EPS (diluted)$2.87+43.5%

Balance sheet

See full
Cash & equivalents$726.4M+38.5%
Total debt$13.3B+6.7%
Total equity-$755.5M-183%
Total assets$17.5B+2.2%

Cash flow

See full
Operating cash flow$320.8M+78.2%
CapEx$102.0M-28.8%
Free cash flow$218.8M+495%

Valuation

See full
Market cap$13.34B-16.0%
Enterprise value$25.95B-5.5%
P/E17.1×-1.4×
P/S1×-0.3×

Profitability

See full
Operating margin15.1%-0.7pp
Net margin5.6%-1.0pp
FCF margin10.8%-2.8pp

Returns & leverage

See full
Return on equity159.1%+80.9pp
Debt / equity103.6×+92.8×
Current ratio1.4×+0.2×

Where this comes from

Reported directly by DaVita in its filing.

Tagged under the XBRL concept us-gaap:Revenues.

The official record: DaVita’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about DaVita's u.s.dialysis and related lab services — revenue.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is DaVita's u.s.dialysis and related lab services — revenue?
DaVita (DVA) reported u.s.dialysis and related lab services — revenue of $2.92B in Q1 2026.
How has DaVita's u.s.dialysis and related lab services — revenue changed year-over-year?
DaVita's u.s.dialysis and related lab services — revenue increased by 3.9% year-over-year, from $2.81B to $2.92B.
What does u.s.dialysis and related lab services — revenue mean?
The total sales generated from domestic dialysis and related lab services.
How do you interpret u.s.dialysis and related lab services — revenue?
An increase suggests growth in patient volume or favorable shifts in payer mix, while a decrease may indicate loss of market share or regulatory pressure on reimbursement rates.
How does u.s.dialysis and related lab services — revenue compare across companies?
Comparable to net patient service revenue in other healthcare services or specialized clinic-based providers.